Anticancer Drugs Belinostat Oncology Pharmacology Physiotherapy


In this article we will discuss Belinostat (Dosage Overview)

In this article, we will discuss Belinostat (Dosage Overview). So, let’s get started.


Belinostat is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).


Dosing Information
The recommended dosage of Belinostat is 1,000 mg/m² administered over 30 minutes by intravenous infusion once daily on Days 1-5 of a 21-day cycle. Cycles can be repeated every 21 days until disease progression or
unacceptable toxicity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.